A new breast cancer drug is being tested in Manchester, that could be a lifeline to women with the most aggressive form of the disease.
The drug, known as T-DM1, is designed to slow the progress of The treatment increases the survival time of some patients by almost six months.
It also reduces side effects such as hair loss, and gives sufferers a better quality of life
More top news
Boxer Amir Khan awarded a Doctor of Letters by Manchester Metropolitan University for his sporting success and charity work.
A charter plane reportedly carrying Manchester City captain Vincent Kompany skidded off a runway, air investigators have blamed pilot error
Burnley Football Club can confirm that a supporter has been given an indefinite club ban following an incident of racial abuse.